We are live on ! Find out more
HURA

TuHURA Biosciences
HURA

22 hedge funds and large institutions have $1.48M invested in TuHURA Biosciences in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% less ownership

Funds ownership: 0% → 0% (-0%)

8% less funds holding

Funds holding: 24 → 22 (-2)

26% less capital invested

Capital invested by funds: $1.99M → $1.48M (-$515K)

40% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 5

50% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 4

Holders
22
Holders Change
-2
Holders Change %
-8.33%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
+$20.9K
2
Osaic Holdings
Osaic Holdings
Arizona
+$19.4K
3
Millennium Management
Millennium Management
New York
+$5.76K
4
TRCT
Tower Research Capital (TRC)
New York
+$5.76K
5
PFS
Prospera Financial Services
Texas
+$1.44K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$127K
2
Renaissance Technologies
Renaissance Technologies
New York
-$61.2K
3
TSS
Two Sigma Securities
New York
-$24K
4
Two Sigma Investments
Two Sigma Investments
New York
-$18K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$16K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$564K – – –
NCM
2
Nantahala Capital Management
Connecticut
$264K – – –
Geode Capital Management
3
Geode Capital Management
Massachusetts
$226K +$20.9K +29 +10%
Osaic Holdings
4
Osaic Holdings
Arizona
$130K +$19.4K +27 +180%
S
5
swisspartners
Liechtenstein
$109K – – –
State Street
6
State Street
Massachusetts
$46K – – –
BlackRock
7
BlackRock
New York
$36K -$2.16K -3 -5%
Renaissance Technologies
8
Renaissance Technologies
New York
$22K -$61.2K -85 -73%
Northern Trust
9
Northern Trust
Illinois
$18K – – –
VF
10
Virtu Financial
New York
$16K -$9.36K -13 -35%
ECM
11
Evergreen Capital Management
Washington
$10K – – –
RJA
12
Raymond James & Associates
Florida
$6K – – –
Millennium Management
13
Millennium Management
New York
$6K +$5.76K +8 New
TRCT
14
Tower Research Capital (TRC)
New York
$6K +$5.76K +8 New
FNB
15
Farmers National Bank
Kentucky
$4.48K – – –
EVM
16
Eaton Vance Management
Massachusetts
$4K – – –
MWM
17
Maltin Wealth Management
New Jersey
$4K – – –
Morgan Stanley
18
Morgan Stanley
New York
$2K -$1.44K -2 -40%
UBS Group
19
UBS Group
Switzerland
$2K – – –
Koshinski Asset Management
20
Koshinski Asset Management
Illinois
$1.59K – – –
LC
21
Lindbrook Capital
California
$1K – – –
PFS
22
Prospera Financial Services
Texas
$1K +$1.44K +2 New
Citadel Advisors
23
Citadel Advisors
Florida
– -$127K -142 Closed
TSS
24
Two Sigma Securities
New York
– -$24K -27 Closed
Two Sigma Investments
25
Two Sigma Investments
New York
– -$18K -20 Closed
1
2

HURA Hedge Fund Activity: Q1 2022 in Review

22 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in TuHURA Biosciences (HURA) for Q1 2022, worth a combined $1.48M — down 26% from $1.99M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of HURA and 3 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 2 added.

The largest buyer was Geode Capital Management, adding an estimated $20.9K. The largest seller was Citadel Advisors, exiting entirely with an estimated $127K sold.

  • 22 institutional investors held TuHURA Biosciences (HURA) as of Q1 2022, down from 24 in Q4 2021.
  • Funds reported $1.48M of TuHURA Biosciences stock for Q1 2022, down 26% quarter-over-quarter.
  • 3 funds opened new TuHURA Biosciences positions in Q1 2022 and 5 closed out, a net change of -2 holders.
  • The largest TuHURA Biosciences buyer in Q1 2022 was Geode Capital Management, an estimated $20.9K added.
  • The largest TuHURA Biosciences seller in Q1 2022 was Citadel Advisors, an estimated $127K sold.

Based on aggregated 13F filings for Q1 2022.